We sit down with you and build your perfect lead list. Book a call with founders.

Talus Bioscience Analysis: $11M Raised

What is Talus Bioscience?

Talus Bioscience develops drugs targeting "undruggable" transcription factors to treat cancer and diabetes using functional proteomics and machine learning.

Employees
16
Founded
2020
Revenue
$1-5M
Company Stage
Seed
YC Batch
S21

Product Features & Capabilities

  • MARMOT platform for targeting transcription factors, functional proteomics, automated biology, machine learning for drug development, focus on hard-to-treat transcription factor proteins.

How much Talus Bioscience raised

1 - $11.2 million

August 20, 2024
Lead Investor: Two Bear Capital

Who are the founders of Talus Bioscience

Investors

  • Two Bear Capital
  • WRF Capital
  • NFX
  • YC Continuity Fund
  • Funders Club VC
  • BoxOne Ventures

Find more companies like Talus Bioscience

in Y Combinator batch S21 companies

Financial Overview

$1-5MEstimated Revenue
$11MTotal Raised
1$11.2 million
August 20, 2024
Investors: Two Bear Capital
Want to research more data points on Talus Bioscience?
Start with Extruct